1. Home
  2. TSLX vs QURE Comparison

TSLX vs QURE Comparison

Compare TSLX & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$21.68

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$24.50

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
QURE
Founded
2010
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
TSLX
QURE
Price
$21.68
$24.50
Analyst Decision
Buy
Strong Buy
Analyst Count
10
12
Target Price
$23.50
$58.55
AVG Volume (30 Days)
427.6K
2.8M
Earning Date
11-04-2025
11-10-2025
Dividend Yield
9.42%
N/A
EPS Growth
N/A
N/A
EPS
2.04
N/A
Revenue
$464,512,000.00
$15,751,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$158.05
P/E Ratio
$10.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.58
$7.76
52 Week High
$25.17
$71.50

Technical Indicators

Market Signals
Indicator
TSLX
QURE
Relative Strength Index (RSI) 44.85 43.01
Support Level $21.62 $19.29
Resistance Level $22.00 $28.50
Average True Range (ATR) 0.29 1.65
MACD -0.04 0.90
Stochastic Oscillator 6.39 67.30

Price Performance

Historical Comparison
TSLX
QURE

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: